Meredith E Jones

US Patent:

20090265279, Oct 22, 2009

Filed:

Apr 18, 2008

Appl. No.:

12/106159

Inventors:

Gerald D. Mintz - Greenwich CT, US
Roger Portnoy - London, GB
Gary L. Metzker - Reno NV, US
Keith A. Knight - Sparks NV, US
John M. Pettit - Reno NV, US
Meredith A. Jones - Nashville TN, US

Assignee:

Strategic Financial Solutions, LLC - New York NY

International Classification:

G06Q 40/00
H04L 9/28

US Classification:

705 71, 705 36 R, 705 64

Abstract:

A system for managing hedge funds includes a storage unit operable to store hedge fund information. The hedge fund information comprises at least one of a fund name, a fund share class, and denominated currency of a fund share class for a hedge fund. The system further includes a determination unit operable to determine, upon receiving hedge fund information, if the hedge fund information corresponds to a known hedge fund based on the received hedge fund information. The determination unit is operable to compare hedge fund information from a plurality of information sources so as to confirm whether the received hedge fund information relates to the same hedge fund.

US Patent:

20230130038, Apr 27, 2023

Filed:

Oct 31, 2022

Appl. No.:

17/977788

Inventors:

- Carlsbad CA, US
Chao Yan LIU - Germantown MD, US
Jeffrey ROGERS - San Diego CA, US
Maria Isabel CISNEROS - San Diego CA, US
Jingqui LI - San Diego CA, US
Henry C. CHIOU - Encinitas CA, US
Meredith Bauman JONES - Chapel Hill NC, US

International Classification:

C07K 14/505
C12N 5/00
C12N 5/0793

Abstract:

High-yield mammalian transient expression systems can include a cell culture media (particularly serum free, non-animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.

US Patent:

20190077841, Mar 14, 2019

Filed:

Jul 26, 2018

Appl. No.:

16/046641

Inventors:

- Carlsbad CA, US
Chao Yan LIU - Germantown MD, US
Jeffrey ROGERS - San Diego CA, US
Maria CISNEROS - San Diego CA, US
Jingqiu LI - San Diego CA, US
Henry CHIOU - Encinitas CA, US
Meredith JONES - Chapel Hill NC, US

International Classification:

C07K 14/505
C12N 5/0793
C12N 5/00

Abstract:

High-yield mammalian transient expression systems can include a cell culture media (particularly serum free, non-animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.